Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study

Table 5 Comparison of prognostic accuracy of different scoring systems across groups according to hepatitis B virus and hepatitis C virus infection status at 12 months and 36 months after treatment

Infection status	Score	Time in months	AUC	χ2	LRT P value	AIC	Mean error	90% quantile
HBV	BCLC	12	0.821	88.70	4.60 10-21	279.18	0.272	0.514
		36	0.828	83.73	5.68 10-20	203.91	0.307	0.789
	HKLC_9	12	0.810	71.63	2.59 10-17	296.24	0.289	0.711
		36	0.809	63.58	1.54 10-15	224.05	0.358	0.723
	HKLC_5	12	0.806	68.18	1.49 10-16	299.69	0.294	0.641
		36	0.808	62.92	2.16 10-15	224.71	0.358	0.655
HCV	BCLC	12	0.831	72.13	2.01 10-17	206.34	0.246	0.614
		36	0.842	70.31	5.06 10-17	156.26	0.298	0.725
	HKLC_9	12	0.872	93.74	3.60 10-22	184.73	0.211	0.631
		36	0.885	85.92	1.87 10-20	140.66	0.271	0.769
	HKLC_5	12	0.875	94.19	2.87 10-22	184.28	0.213	0.687
		36	0.891	89.75	2.70 10-21	136.83	0.261	0.666
Non-B-Non-C	BCLC	12	0.751	35.75	2.24 10-9	174.21	0.372	0.732
		36	0.802	31.49	2.01 10-8	97.07	0.293	0.639
	HKLC_9	12	0.812	45.84	1.28 10-11	164.12	0.342	0.731
		36	0.878	45.90	1.25 10-11	82.66	0.256	0.669
	HKLC_5	12	0.797	41.21	1.36 10-10	168.74	0.355	0.750
		36	0.880	47.89	4.50 10-12	80.66	0.244	0.602

AUC: Area under the curve; AIC: Akaike information criterion; LRT: Likelihood ratio test; HBV: Hepatitis B virus; HCV: Hepatitis C virus; BCLC: Barcelona Clinic Liver Cancer; HKLC: Hong Kong Liver Cancer.